News of Note—Altimmune, Ebola outbreak and more

newspaper
(Pixabay)

Here is some other vaccine news of note for the week:

> Altimmune CEO Bill Enright plans to step down from his post early next year, or when a successor is appointed. Washington Business Journal article

> Teams fighting the Ebola outbreak are struggling to find potential vaccine recipients. Stat News article

Free Daily Newsletter

Like this story? Subscribe to FiercePharma!

Biopharma is a fast-growing world where big ideas come along daily. Our subscribers rely on FiercePharma as their must-read source for the latest news, analysis and data on drugs and the companies that make them. Sign up today to get pharma news and updates delivered to your inbox and read on the go.

> Seqirus' Afluria Quadrivalent won a label expansion in the U.S. It's now approved for people 6 months and older. Release

Read more on